Literature DB >> 27753005

Infantile Systemic Hyalinosis: Novel Founder Mutation in the Initiation Codon among "Malis (Farmers)" in Jodhpur.

Jai Prakash Soni1, Ratna D Puri2, Kapil Jetha3, G S L Bhavani3, Monika Chaudhary3, Sudha Kohli2, I C Verma4.   

Abstract

Infantile systemic hyalinosis (OMIM 236490) is a progressive autosomal recessive disorder characterized by widespread deposition of hyaline material in many tissues leading to multiple subcutaneous skin nodules, gingival hypertrophy and joint contractures. The authors describe five children from four unrelated families, from the "mali (farmer)" community in Jodhpur, with the disorder. All of them had classical clinical features, and four died from severe infections between age of 7 mo to 3 y. Two affected children had the same, but novel mutation in the initiation codon, in homozygous form c.1 A > G; p. M1? in capillary morphogenesis protein-2 (CMG2), or ANTXR2 gene on chromosome 4q21.21. The other two parents had the same mutation in heterozygous form. It is likely that this is a founder mutation in this community.

Entities:  

Keywords:  ANTXR2 gene; CMG2 gene; Hyaline fibromatosis syndrome; Infantile systemic hyalinosis (ISH); “Mali (farmer) community in Jodhpur”

Mesh:

Substances:

Year:  2016        PMID: 27753005     DOI: 10.1007/s12098-016-2218-8

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN: 0019-5456            Impact factor:   1.967


  27 in total

1.  Infantile Systemic Hyalinosis with Mutation in ANTXR2.

Authors:  Dhanya Lakshmi Narayanan; Shubha R Phadke
Journal:  Indian J Pediatr       Date:  2016-01-25       Impact factor: 1.967

Review 2.  Infantile systemic hyalinosis: Case report and review of the literature.

Authors:  Lisa E Lindvall; Tanya Kormeili; Elaine Chen; Maria Celeste M Ramirez; Valerie Grum-Tokars; Marc J Glucksman; John A Martignetti; Michael V Zaragoza; Senait W Dyson
Journal:  J Am Acad Dermatol       Date:  2008-02       Impact factor: 11.527

3.  Infantile systemic hyalinosis in an Iranian family with a mutation in the CMG2/ANTXR2 gene.

Authors:  H Vahidnezhad; V Ziaee; L Youssefian; Q Li; S Sotoudeh; J Uitto
Journal:  Clin Exp Dermatol       Date:  2015-03-07       Impact factor: 3.470

4.  Infantile systemic hyalinosis: a fatal disorder commonly diagnosed among Arabs.

Authors:  S M Al-Mayouf; A AlMehaidib; S Bahabri; S Shabib; N Sakati; A S Teebi
Journal:  Clin Exp Rheumatol       Date:  2005 Sep-Oct       Impact factor: 4.473

Review 5.  Infantile systemic hyalinosis presenting as intractable infantile diarrhea.

Authors:  Luluah Al-Mubarak; Abdulkarim Al-Makadma; Sultan Al-Khenaizan
Journal:  Eur J Pediatr       Date:  2008-06-18       Impact factor: 3.183

6.  Systemic hyalinosis or fibromatosis hyalinica multiplex juvenilis as a congenital syndrome. A new entity based on the inborn error of the acid mucopolysaccharide metabolism in connective tissue cells?

Authors:  H Ishikawa; S Mori
Journal:  Acta Derm Venereol       Date:  1973       Impact factor: 4.437

Review 7.  Systemic Hyalinosis With Heterozygous CMG2 Mutations: A Case Report and Review of Literature.

Authors:  Maral Rahvar; Joyce Teng; Jinah Kim
Journal:  Am J Dermatopathol       Date:  2016-05       Impact factor: 1.533

8.  Juvenile hyaline fibromatosis. A histologic and histochemical study.

Authors:  A Mayer-da-Silva; A Poiares-Baptista; F Guerra Rodrigo; M Teresa-Lopes
Journal:  Arch Pathol Lab Med       Date:  1988-09       Impact factor: 5.534

9.  Infantile systemic hyalinosis in identical twins.

Authors:  Mahesh Kumar Koonuru; Satya Prasad Venugopal
Journal:  Intractable Rare Dis Res       Date:  2015-11

10.  The gene for juvenile hyaline fibromatosis maps to chromosome 4q21.

Authors:  Nazneen Rahman; Melanie Dunstan; M Dawn Teare; Sandra Hanks; Sarah J Edkins; Jaime Hughes; Graham R Bignell; Grazia Mancini; Wim Kleijer; Mary Campbell; Gokhan Keser; Carol Black; Nigel Williams; Laura Arbour; Matthew Warman; Andrea Superti-Furga; P Andrew Futreal; F Michael Pope
Journal:  Am J Hum Genet       Date:  2002-09-04       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.